Key result
Acetylsalicylic acid (300 mg) prolonged bleeding time in 82% of essential thrombocythemia patients compared to 27% of healthy volunteers, linked to effects on the lipoxygenase pathway.
Why the study?
Does acetylsalicylic acid affect the lipoxygenase pathway and bleeding time differently in patients with essential thrombocythemia compared to healthy volunteers?
Population
Patients with essential thrombocythemia (ET) and healthy volunteers
Comparison
Acetylsalicylic acid (ASA) 300 mg taken orally vs Healthy volunteers receiving the same dose of ASA
Design
Cohort
Authors
Loading...
May warrant caution with aspirin in essential thrombocythemia; leaves open whether lipoxygenase effects should guide dosing.
Observational
Does acetylsalicylic acid affect the lipoxygenase pathway and bleeding time differently in patients with essential thrombocythemia compared to healthy volunteers?
Absolute Event Rate: 82% vs 27%
Aspirin prolongs bleeding time in a significantly higher percentage of patients with essential thrombocythemia compared to healthy volunteers, likely due to differential effects on the lipoxygenase pathway.
Cortelazzo et al. (1998) conducted an observational in Essential thrombocythemia. Acetylsalicylic acid (ASA) vs. Healthy volunteers was evaluated on Prolongation of bleeding time. Acetylsalicylic acid (300 mg) prolonged bleeding time in 82% of essential thrombocythemia patients compared to 27% of healthy volunteers, linked to effects on the lipoxygenase pathway.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: